Latest Study Analysis “Life Sciences Aggregate-Spending Market 2022 Global Market Opportunities, Challenges, Strategies and Forecasts 2032”- Persistence Market Research.
Sales in the life sciences aggregate-spending market were US$ 974.2 Mn in 2021, and the market is projected to expand rapidly at a CAGR of 10% over the forecast period (2022-2032). Growing importance of data privacy, transparency, and anti-bribery laws are augmenting market expansion globally
Aggregate-spending or sunshine law tracking involves the monitoring and reporting of money invested by pharmaceutical, life science, and medical device manufacturers in maintaining and building new relationships with physicians and other healthcare providers.
The U.S. federal government implemented the Sunshine law or the Physicians Open Payment Act in 2010, with the objective to provide transparency in the life science industry, mandate statutory reports every year, and limit the influence of these manufacturers on healthcare professionals. Soon enough, several countries around the world realized the benefits of this law and started implementing similar laws or regulations in their healthcare sector.
In 2018, Saudi Arabia, Bosnia-Herzegovina, and Columbia also implemented Sunshine-law like regulations. Burgeoning popularity of this law forms the basis of the promising growth of the life sciences aggregate-spending market over the forecast period.
Request for sample copy of report: https://www.persistencemarketresearch.com/samples/13594
According to a survey published by IQVIA concerning aggregate-spending trends around the world, blooming investments in the healthcare market of the U.S. and Europe are likely to intensify. Stringent regulations revolving around malpractices and bribes are favoring pharma and medical device manufacturers to expand their business in these countries.
Data privacy and patient consent are rapidly gaining importance in the healthcare industry. With the COVID-19 pandemic and rising influence of IT in healthcare, awareness regarding data privacy has grown exponentially.
For instance, the proposed Digital Information Security in Healthcare Act (DISHA) submitted in 2018, by the Ministry of Health and Family Welfare, highlighted the goal of securing healthcare data in India and providing consumers complete ownership of their health data.
Efforts taken by governments around the world are also providing the necessary momentum to aggregate-spend report-developing companies to grow globally.
For instance, recently, in 2021, Ireland and France also updated their transparency reporting laws to curtail unethical practices.
A few key players dominate the life sciences aggregate-spending market, which exhibits many beneficial opportunities for new entrants as well. Snowballing demand for global aggregate-spend reporting solutions is stimulating the progress of the life sciences aggregate-spending market.
Get customized report as per requirement: https://www.persistencemarketresearch.com/request-customization/13594
Market Study Analysis:
- Third-party engagement solutions help healthcare organizations keep a track of all expenses that go to third parties, such as physicians, vendors, etc. Since regulations mandate manufacturers to report their yearly spending to all third parties, this solution netted 36.4% market share in terms of revenue in 2021.
- Cloud-based deployment of aggregate-spending solutions helps providers as well as users of these solutions access large amounts of data in one go. Cloud-based solutions accounted for 64% sales of this market in 2021.
- More than 43% market was bagged by medium-sized businesses in the global life sciences aggregate-spending market in 2021.
- Pharmaceutical companies use aggregate-spend reporting solutions more than other end users, since they are in close interaction with healthcare organizations and providers all year long. This segment holds nearly half of the revenue share in the global market.
- North America accounted for 84.5% share in terms of revenue in the global life sciences aggregate-spending market in 2021, due to the highest percentage of adoption in this country.
“Increased governmental scrutiny over unethical practices along with rising healthcare expenditure globally is driving life sciences aggregate-spending growth,” says an analyst of Persistence Market Research.
Get full access of report: https://www.persistencemarketresearch.com/checkout/13594
Competitive Analysis:
Solution providers in this industry such as Qordata, IQVIA, and MedPro Systems LLC, amongst others, are employing strategies such as innovative products and services launches, and forming strategic alliances with other companies, which would prove beneficial for their business to expand even further in the global market.
In October 2020, Qordata entered into a strategic partnership with SAP Concur, which is the healthcare industry’s most-widely used spend management service provider. This partnership paved the way for a faster exchange of SAP Concur’s database to Qordata’s Compliance Suite to enhance their reporting services for medicine and device manufacturing companies.
In June 2021, MedPro Systems and its Compliance Advisory Services team announced a partnership with PharmaCertify, the compliance training division of NXLevel Solutions, to help life science organizations implement more effective and cohesive compliance programs.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the life sciences aggregate-spending market in its latest study, presenting historical demand assessment of 2017-2021 and projections for 2022-2032.
The research study is based on the solution (third-party engagement solutions, aggregate spend reporting solutions, in-house software systems, and manually with spreadsheets), deployment (web-based deployment and cloud-based deployment), business type (small businesses, medium businesses, and large enterprises), end user (pharmaceutical companies, medical device manufacturers, biotechnology & life sciences companies, and healthcare settings), and region (North America, Europe, APAC, and the Rest of the World)
Want More Valuable Insights?
Persistence Market Research brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cell culture media Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights into the cell culture media market. The market is segmented into five parts based on product (serum containing media, serum-free media, protein free media, and chemically defined media) based on application (cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, stem cell technologies, and others) based on the end user (biopharmaceutical companies, clinical research organizations, and academic research centers), and across seven major regions.
Related Reports:
- Orthopedic Veterinary Implants Market
- Orthopedic Surgical Robots Market
- Operating Tables Market
- Orally Disintegrating Tablet Market
- Cosmetic Peptide Synthesis Market
- Healthcare Mobility Solutions Market
- US Respiratory Syncytial Virus Vaccines Market
- Quadriplegia Care Devices Market
- Europe Dental Imaging Equipment Market
About Persistence Market Research:
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact
Rajendra Singh
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA – Canada Toll-Free: 800-961-0353